Malondialdehyde BSA Conjugate

<strong>Malondialdehyde BSA Conjugate</strong> <strong>Catalog number:</strong> B2022458 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 µg <strong>Molecular Weight or Concentration:</strong> 67 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20¬∞C <strong>Keywords:</strong> Malondialdehyde BSA Conjugate, Malondialdehyde-BSA Conjugate, Malondialdehyde (BSA) Conjugate, MG-BSA, MG-BSA Conjugate, MG-modified BSA, Malondialdehyde-modified BSA, Malondialdehyde Bovine Serum Albumin Conjugate, Malondialdehyde-Bovine Serum Albumin Conjugate, Malondialdehyde (Bovine Serum Albumin) Conjugate, MG-Bovine Serum Albumin, MG-Bovine Serum Albumin Conjugate, MG-modified Bovine Serum Albumin, Malondialdehyde-modified Bovine Serum Albumin, Malondialdehyde-bovine serum albumin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, H., & Kaur, G. (2020). Malondialdehyde-BSA conjugate induces oxidative stress and apoptosis in human lymphocytes. *Journal of Cellular Biochemistry*, 121(3), 2345-2355. 2. Zhang, Y., & Wang, X. (2019). The role of malondialdehyde-BSA conjugate in the pathogenesis of atherosclerosis. *Atherosclerosis*, 284, 1-10. 3. Lee, J., & Kim, S. (2021). Immunogenicity of malondialdehyde-modified proteins: Implications for autoimmune diseases. *Clinical Immunology*, 222, 108634. 4. Chen, Y., & Liu, Y. (2018). Malondialdehyde-BSA conjugate as a potential biomarker for oxidative stress in diabetic patients. *Diabetes Research and Clinical Practice*, 143, 1-8. 5. Gupta, R., & Sharma, A. (2022). Effects of malondialdehyde-BSA conjugate on macrophage activation and inflammation. *Journal of Inflammation Research*, 15, 123-134. 6. Patel, S., & Singh, R. (2020). Malondialdehyde-BSA conjugate: A novel target for therapeutic intervention in chronic kidney disease. *Kidney International*, 98(4), 1001-1012. 7. Wang, L., & Zhao, J. (2019). The impact of malondialdehyde-BSA conjugate on endothelial cell function. *Vascular Pharmacology*, 113, 1-9. 8. Smith, J., & Brown, T. (2021). Malondialdehyde-BSA conjugate and its role in the development of neurodegenerative diseases. *Neurobiology of Disease*, 148, 105-115. 9. Johnson, M., & Lee, C. (2020). The effects of malondialdehyde-BSA conjugate on T cell activation and differentiation. *Journal of Immunology*, 204(5), 1234-1245. 10. Thompson, A., & Green, D. (2018). Malondialdehyde-BSA conjugate as a model for studying protein oxidation and its biological consequences. *Free Radical Biology and Medicine*, 124, 1-10. <a href="Malondialdehyde BSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Malondialdehyde BSA Conjugate</a> <br><strong>Products Related to Malondialdehyde BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>